NCT01884051View on ClinicalTrials.gov

Hormonal, Metabolic, and Signaling Interactions in PAH

RecruitingOBSERVATIONAL

Enrollment

1,899

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2032

Study Completion Date

July 31, 2032

Conditions

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionScleroderma Associated Pulmonary Arterial HypertensionAppetite Suppressant Associate PAH

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER